Context
Lattice Medical is a biomedical startup developing biodegradable breast implants designed to support natural tissue regeneration after cancer surgery.
Their patented technology, Mattisse, combines 3D printing and bioabsorbable materials to enable safer and more efficient breast reconstruction while reducing the need for multiple surgeries.
The Challenge
During R&D, Lattice Medical faced a major challenge. Their implant material, a specialized bioabsorbable polymer, costs approximately €5000 per kilogram. This made experimentation extremely expensive and required a workflow that could support precise testing while minimizing material waste.
The Challenge
To support efficient experimentation with costly bioabsorbable polymers, Lattice Medical implemented an in-house workflow that enables specialized materials to be converted into filament and tested through prototype implant geometries.
This approach allows researchers to evaluate material behavior, optimize processing parameters, and iterate rapidly while maintaining strict control over material usage.
/3devo%20Logo%20Borderless%20-%20Dark%20Mode.png?width=200&height=64&name=3devo%20Logo%20Borderless%20-%20Dark%20Mode.png)